1.
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
by Yoshida, Reiko
Breast cancer (Tokyo, Japan), 2020-08-29, Vol.28 (6), p.1167-1180
2.
Population genetic screening efficiently identifies carriers of autosomal dominant diseases
by Grzymski, J J
Nature medicine, 2020-08, Vol.26 (8), p.1235-1239
3.
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
by Arai, Masami
Journal of human genetics, 2018-04, Vol.63 (4), p.447-457
4.
Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model
by Karthikeyan, Subbulakshmi
Cancer letters, 2018-10-01, Vol.433, p.221-231
5.
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families
by Li, Jun Jun
Journal of medical genetics, 2015-11-03, Vol.53 (1), p.34-42
6.
Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
by Randall, Thomas C
Current Treatment Options in Oncology, 2016-06-17, Vol.17 (8), p.39-39
7.
A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
by Oronsky, Bryan
Medical oncology (Northwood, London, England), 2017-04-25, Vol.34 (6), p.103
8.
Epigenetic biomarkers in epithelial ovarian cancer
by Gloss, Brian S
Cancer letters, 2012, Vol.342 (2), p.257-263
9.
Tumor microenvironment: the culprit for ovarian cancer metastasis?
by Luo, Zhongyue
Cancer letters, 2016, Vol.377 (2), p.174-182
10.
Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark
by Yang, Shan
Annals of surgical oncology, 2018-07-11, Vol.25 (10), p.2925-2931
11.
Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
by Zhang, Yuan
Cancer letters, 2011, Vol.303 (1), p.47-55
12.
TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA
by Hu, Yuan
Cancer letters, 2017, Vol.393, p.60-67
13.
The use of natural compounds for the targeting and chemoprevention of ovarian cancer
by Pistollato, Francesca
Cancer letters, 2017-12-28, Vol.411, p.191-200
14.
Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium
by Nakamura, Seigo
Public health genomics, 2016-01-01, Vol.19 (1), p.53-60
15.
Epidemiology and treatment patterns of epithelial ovarian cancer
by Jessmon, Philip
Expert review of anticancer therapy, 2017-05-04, Vol.17 (5), p.427-437
16.
Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas
by Petersen, Shariska
The American journal of surgery, 2021-04, Vol.221 (4), p.712-717
17.
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
by Brohet, Richard M
Journal of medical genetics, 2014-02, Vol.51 (2), p.98-107
18.
Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis
by Shi, Mingxin
Biology of reproduction, 2020-01-13, Vol.102 (5), p.1055-1064
19.
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
by Luvero, Daniela
Therapeutic Advances in Medical Oncology, 2014-09, Vol.6 (5), p.229-239
20.
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature
by Capriglione, Stella
Medical oncology (Northwood, London, England), 2017-08-20, Vol.34 (9), p.164-164
